Latest News-Porda Havas International Financial Communications Group Mediaroom_Page

Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Administration

HONG KONG, May 24, 2021 /PRNewswire/ -- Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or t...

2021-05-24 16:58 5256

Viva Biotech and BioMap Reached a Strategic Collaboration Agreement, To Jointly Accelerate the Early Drug Discovery through AI Technology

SHANGHAI, May 10, 2021 /PRNewswire/ -- Hosted by BioMap and Adock, the first generation of China Bi...

2021-05-10 18:21 2548

Viva Biotech Announced 2020 Annual Results

The Group's Revenue Surged by 115.7% YoY Revenue from the CFS Business Increased Significantly by ...

2021-03-31 07:03 3427

Hang Seng Ping An Asian Income Fund Offers Investors Chance to Capture Long-term Growth in Asian Market

HONG KONG, March 29, 2021 /PRNewswire/ -- The Hang Seng Ping An Asian Income Fund# (the 'Fund') ope...

2021-03-29 18:12 1827

Ocumension Therapeutics (1477.HK) Reports Revenue Growth in 2020, National Commercial Construction has been started to become outstanding

HONG KONG, March 20, 2021 /PRNewswire/ -- The Chinese ophthalmology platform company,Ocumension The...

2021-03-20 18:20 8726

Sihuan Pharmaceutical (0460.HK): 'A Friend of Time' 2021 - The Turning-point Year

HONG KONG, March 16, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. plays a pivotal...

2021-03-16 14:48 3539

Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders

SHANGHAI, March 10, 2021 /PRNewswire/ -- March 2nd-6th, 2021, Viva Biotech successfully hosted the ...

2021-03-10 20:18 6813

Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders

Sihuan Pharmaceutical (0460.HK): Be a friend of time, 2021 is the year of turning point

HONG KONG, March 10, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. plays a pivotal...

2021-03-10 15:02 3283

World's First PMOLED TDDI IC Revolutionises Smart Home Appliance Manufacturing with Enhanced "Touch + Display" User Experience

HONG KONG, Feb. 10, 2021 /PRNewswire/ -- Solomon Systech Limited ("Solomon Systech", a wholly-owned...

2021-02-10 17:30 3647

Sihuan Pharmaceutical (0460.HK) The sole agent of Letybo 100U China AI Listing Conference was successfully held

HONG KONG, Feb. 5, 2021 /PRNewswire/ -- Exclusively represented by Sihuan Pharmaceutical Holdings G...

2021-02-05 11:32 5114

Sihuan Pharmaceutical (0460.HK) The sole agent of Letybo 100U China AI Listing Conference was successfully held

Sihuan Pharmaceutical (0460.HK): Xuanzhu Biopharm acquires Combio Pharmaceutical, the large-molecule integrated development platform helps drive innovation

HONG KONG, Jan. 27, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" o...

2021-01-27 11:21 6823

NTC grants to Zhaoke exclusive license and distribution rights in Asia for NTC014, innovative drug for bacterial conjunctivitis

MILAN and HONG KONG, Jan. 8, 2021 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical ...

2021-01-08 20:55 5373

Ping An of China Asset Management (Hong Kong) Wins Two Prestigious Awards

HONG KONG, Dec. 31, 2020 /PRNewswire/ -- Ping An of China Asset Management ( Hong Kong) Company Limi...

2020-12-31 16:00 3141

Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Viva Biotech's Online Investor Day was successfully hosted ...

2020-12-14 12:15 2453

Yincheng Life Service Controlling Shareholder Increased its Shareholding of 4,160,000 Shares

HONG KONG, Dec. 7, 2020 /PRNewswire/ -- The leading regional property management enterprise in the ...

2020-12-07 20:37 4565

Sihuan Pharmaceutical (0460) Won the Fifth "Listed Enterprises of the Year 2020" Presented by Bloomberg Businessweek/Chinese Edition

HONG KONG, Dec. 3, 2020 /PRNewswire/ -- Bloomberg Businessweek/Chinese Edition announced thatSihuan...

2020-12-03 10:36 8594

Sihuan Pharmaceutical (0460.HK) receives approval for its exclusive medical aesthetic product Letybo (botulinum toxin), A blockbuster product in a hundred-billion size market

HONG KONG, Oct. 27, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460) is ...

2020-10-27 10:42 6373

Latest News